Intra- and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone.
To study facial flush after systemic administration of human corticotropin-releasing hormone (hCRH) we injected 100 micrograms hCRH intravenously to ten healthy young men. The increase in facial temperature was measured by infrared camera. A significant increase in facial temperature of 1.39 degrees C +/- 0.3 was found within 7 min in all patients, which lasted up to 60 min, although facial flushing was visible in only 50% (5/10) of the probands. In a second experiment 100 micrograms hCRH was then administered to seven other healthy young men. Intra- and extracerebral blood flow velocity changes in the medial cerebral artery (MCA) and external carotid artery (ECA) were measured after hCRH administration by use of Doppler sonography. We found a decrease of intracerebral blood flow which was caused by hyperventilation and was reversible following 6% CO2 hyperventilation during a second injection of 100 micrograms hCRH. Blood flow velocity in the ECA increased by 111.5 +/- 32.9% (compared to baseline level), lasted up to 60 min after hCRH injection, and was not reversible by 6% end-tidal CO2 ventilation. We thus demonstrated that the direct vasodilatory effect of hCRH involves the ECA-supplied vascular territory only. The intracerebral vasoconstrictory effect represents the result of hyperventilation following hCRH injection. The data thus clearly suggest an interaction of hCRH and the vascular endothelium of the ECA, causing a marked blood flow velocity increase and facial flushing.
Kübler
A
A
III. Medizinische Klinik, Johannes Gutenberg-Universität, Mainz, Germany.
Rothacher
G
G
Knappertz
V A
VA
Krämer
G
G
Nink
M
M
Beyer
J
J
Lehnert
H
H
D000328:Adult; D002342:Carotid Artery, External; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000187:drug effects; D005145:Face / Q000098:blood supply*; D005483:Flushing / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D006985:Hyperventilation / Q000503:physiopathology; D007275:Injections, Intravenous; D008297:Male; D012881:Skin Temperature / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D003346:Corticotropin-Releasing Hormone